Anthem Blue Cross and Blue Shield Nevada policy
Gene Therapy for Duchenne Muscular Dystrophy
Gene Therapy for Duchenne Muscular Dystrophy is a public Anthem Blue Cross and Blue Shield Nevada policy (policy MED.00144). It lists 1 CPT or HCPCS code, 1 of them on the Anthem Blue Cross and Blue Shield Nevada prior authorization list. Not a coverage decision; the payer's own document governs.
- Policy number
- MED.00144
- Line of business
- Commercial
- Source
- www.anthem.com
Codes in this policy
The CPT and HCPCS codes the policy names. A policy can name a code it excludes. Prior authorization status is from the Anthem Blue Cross and Blue Shield Nevada prior authorization list.
| Code | Prior authorization | Description on the prior authorization list | Other Anthem Blue Cross and Blue Shield Nevada policies |
|---|---|---|---|
| J1413 | On the list | Injection, delandistrogene moxeparvovec-rokl, per therapeutic dose | Policies naming J1413 |
All Anthem Blue Cross and Blue Shield Nevada policies · Anthem Blue Cross and Blue Shield Nevada prior authorization CPT list